GLA
TEVA icon

Great Lakes Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Great Lakes Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,926
Closed -$1.18M – 554
2015
Q1 		$1.18M Sell
18,926
-59
-0.3% -$3.43K 0.04% 305
2014
Q4 		$1.09M Buy
18,985
+2,374
+14% +$132K 0.03% 300
2014
Q3 		$893K Buy
16,611
+609
+4% +$32.3K 0.03% 320
2014
Q2 		$839K Buy
16,002
+653
+4% +$33.4K 0.03% 212
2014
Q1 		$811K Sell
15,349
-214
-1% -$9.89K 0.04% 216
2013
Q4 		$623K Buy
15,563
+1,940
+14% +$76.4K 0.03% 210
2013
Q3 		$515K Buy
13,623
+1,440
+12% +$56.2K 0.02% 240
2013
Q2 		$478K Buy
+12,183
New +$474K 0.02% 239

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Great Lakes Advisors's TEVA Position: Q2 2015 in Review

Great Lakes Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 18,926 shares — an estimated $1.18M sold.

Great Lakes Advisors first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.18M in Q1 2015. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Great Lakes Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Great Lakes Advisors sold 18,926 Teva Pharmaceuticals shares in Q2 2015, an estimated $1.18M.
  • Great Lakes Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Great Lakes Advisors's Teva Pharmaceuticals position peaked at $1.18M in Q1 2015.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Great Lakes Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.